HSBC HOLDINGS PLC - TCR2 THERAPEUTICS INC ownership

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$25,540
+51.0%
17,2570.0%0.00%
Q4 2022$16,910
-48.8%
17,257
-8.2%
0.00%
Q3 2022$33,000
-41.1%
18,801
-1.5%
0.00%
Q2 2022$56,000
+5.7%
19,0940.0%0.00%
Q1 2022$53,000
-42.4%
19,0940.0%0.00%
Q4 2021$92,00019,0940.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$62,221,00018.51%
MPM BioImpact LLC 3,370,982$51,778,00013.77%
Redmile Group, LLC 1,765,188$27,113,0000.50%
ArrowMark Colorado Holdings LLC 1,356,010$20,828,0000.22%
DAFNA Capital Management LLC 46,183$709,0000.20%
Artal Group S.A. 350,000$5,376,0000.15%
WFA of San Diego, LLC 4,733$540,0000.13%
Granite Point Capital Management, L.P. 100,000$1,536,0000.08%
HHLR ADVISORS, LTD. 322,903$4,960,0000.04%
SPHERA FUNDS MANAGEMENT LTD. 30,000$461,0000.04%
View complete list of TCR2 THERAPEUTICS INC shareholders